Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
Laura C FanucchiSean M MurphyHilary SurrattShashi N KapadiaSharon L WalshJames A GrubbsAlice C ThorntonPaul NuzzoMichelle R LofwallPublished in: Therapeutic advances in infectious disease (2022)
The B-OPAT study will help address the important question of whether it is clinically effective and cost-effective to discharge persons with OUD and SIRI to an integrated outpatient care model combining OUD treatment with OPAT relative to TAU (Clinicaltrials.gov Identifier: NCT04677114).